A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2019
- Vertex Pharmaceuticals Incorporated
A Study to Evaluate the Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2019
- Vertex Pharmaceuticals Incorporated
A Study to Compare US Marketed Pancrelipase Drug Product With Drug Product Manufactured With a Modernized Process at an Alternate Manufacturing Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis. - Phase 4 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2019
- AbbVie
A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CF - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2019
- Heidelberg University
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Effect of Inhaled SNSP113 in Adult Subjects with Cystic Fibrosis
ongoing trials trial from other registries
Details- 2019